Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,073
Closed -$215K 289
2022
Q4
$215K Buy
+5,073
New +$209K 0.07% 247
2022
Q2
Sell
-6,757
Closed -$244K 300
2022
Q1
$244K Buy
6,757
+1,589
+31% +$54.5K 0.07% 269
2021
Q4
$204K Sell
5,168
-2,022
-28% -$84.3K 0.05% 301
2021
Q3
$314K Buy
+7,190
New +$323K 0.08% 240

Other funds holding GMAB

WrapManager Inc's GMAB Position: Q1 2023 in Review

WrapManager Inc sold out of Genmab (GMAB) in Q1 2023, closing a stake of 5,073 shares — an estimated $215K sold.

WrapManager Inc first reported a position in GMAB in Q3 2021 and held it in 4 quarters. The position peaked at $314K in Q3 2021. 216 funds tracked by Wall St. Rank hold GMAB as of Q1 2023.

  • WrapManager Inc reported no remaining Genmab position as of Q1 2023 after selling out during the quarter.
  • WrapManager Inc sold 5,073 Genmab shares in Q1 2023, an estimated $215K.
  • WrapManager Inc first reported a position in Genmab in Q3 2021 and held it in 4 quarters.
  • WrapManager Inc's Genmab position peaked at $314K in Q3 2021.
  • 216 funds tracked by Wall St. Rank held Genmab as of Q1 2023.

Based on WrapManager Inc's 13F filing for Q1 2023, filed 8 May 2023.